Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | April 23, 2019 | April 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 23, 2019 · Filed April 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 169,935 |
Ending reported balance
After 2019-04-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-04-23 · Exercise / conversion · Acquired 56,000 · Balance 225,935 Row 2 · 2019-04-23 · Sale · Disposed 56,000 · Balance 169,935 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.00 · Expires 2025-02-19 | Direct | 113,227 |
Reported balance
After 2019-04-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-04-23 · Exercise / conversion · Disposed 56,000 · Balance 113,227 F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 1,698 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,698 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy Spouse | 53 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 53 F2: The reporting person disclaims beneficial ownership of all securities held by his spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2011 Filed Mar 2, 2011 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,333 | $47.64 | $396,984.12 |
DisclosureSEC source: 0001179110-11-003910 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,738 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 20, 2011 Filed Feb 23, 2011 23:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 12 | $46.88 | $562.56 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 126 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 19, 2011 Filed Feb 23, 2011 23:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8 | $46.88 | $375.04 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 138 F3 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 23:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 45,800 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,800 Underlying: Common shares · 45,800 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 23:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003285 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,071 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 20,906 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · derivative · entry 15 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 20,906 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,600 | $47.34 | $170,424.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 12 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,571 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $47.34 | $61,535.50 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 11 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,171 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,600 | $47.33 | $217,718.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,471 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,000 | $47.32 | $94,640.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,071 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.32 | $4,731.75 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,071 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 103 | $47.31 | $4,872.93 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,171 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.31 | $4,730.50 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,274 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,350 | $47.30 | $158,455.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,374 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,600 | $47.29 | $217,534.00 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,724 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $47.29 | $14,185.50 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,324 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 853 | $47.28 | $40,329.84 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,624 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| December 13, 2010 Filed Dec 15, 2010 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 20,906 | $45.45 | $950,152.61 |
DisclosureSEC source: 0001179110-10-017575 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,945 | $47.56 | $187,624.20 |
DisclosureSEC source: 0001179110-10-009861 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,571 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $51.16 | $86,972.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 15 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,516 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $51.15 | $56,265.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 14 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,216 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.10 | $5,109.50 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 13 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,316 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.08 | $5,108.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 12 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,416 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $51.07 | $51,070.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 11 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,516 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $51.02 | $10,204.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,516 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $51.01 | $20,404.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,716 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $51.00 | $91,800.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,116 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $50.93 | $45,837.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,916 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $50.86 | $45,774.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,816 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,610 | $50.85 | $641,218.50 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,716 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $50.62 | $20,248.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,326 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 90 | $50.62 | $4,555.35 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,726 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,000 | $50.61 | $101,220.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,816 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 22:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $50.60 | $15,180.00 |
DisclosureSEC source: 0001179110-10-007460 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,816 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,917 | $54.12 | $536,708.04 |
DisclosureSEC source: 0001179110-10-004235 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,116 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 20, 2010 Filed Feb 24, 2010 01:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 14 | $54.38 | $761.32 |
DisclosureSEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 146 F5 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 28,700 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003585 · edgar.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Underlying: Common shares · 28,700 shares Expires 2020-02-18 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 02/19/2011, 9,566 on 02/19/2012, and 9,567 on 02/19/2013. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 160 F6 · shares: These shares represent restricted stock units granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program. The units vest in three equal annual installments on the anniversary of their grant date. F5 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,033 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. F3 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,033 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. F3 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,500 | $53.91 | $80,868.00 |
DisclosureSEC source: 0001179110-10-003136 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,433 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.91 | $10,782.00 |
DisclosureSEC source: 0001179110-10-003136 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,933 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,867 | $53.93 | $316,407.31 |
DisclosureSEC source: 0001179110-10-003136 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,133 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,532 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,532 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,442 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,442 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,597 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,597 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,321 | $0.00 Strike: $48.33 | $0.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,321 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,892 | $53.00 | $789,276.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,000 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,532 | $32.61 | $49,960.21 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,442 | $47.82 | $68,956.44 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.